惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Y
Y Combinator Blog
GbyAI
GbyAI
U
Unit 42
WordPress大学
WordPress大学
Last Week in AI
Last Week in AI
P
Proofpoint News Feed
D
DataBreaches.Net
N
Netflix TechBlog - Medium
H
Hackread – Cybersecurity News, Data Breaches, AI and More
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
C
Check Point Blog
Martin Fowler
Martin Fowler
月光博客
月光博客
MongoDB | Blog
MongoDB | Blog
MyScale Blog
MyScale Blog
The Cloudflare Blog
Apple Machine Learning Research
Apple Machine Learning Research
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
M
MIT News - Artificial intelligence
云风的 BLOG
云风的 BLOG
罗磊的独立博客
B
Blog RSS Feed
J
Java Code Geeks
The GitHub Blog
The GitHub Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Sotera Health Company (SHC) Presents at RBC Capital Marke...
2026-05-20 · via All Articles on Seeking Alpha

Sotera Health Company (SHC) RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 3:05 PM EDT

Company Participants

Jonathan Lyons - Senior VP & CFO

Conference Call Participants

Ryan Halsted - RBC Capital Markets, Research Division

Presentation

Ryan Halsted
RBC Capital Markets, Research Division

Okay. Thank you. We're going to get started. We're going to start the afternoon session. And this afternoon, we're going to start with Sotera Health. Sotera Health is an end-to-end sterilization and lab testing services company that caters to the med-surg equipment manufacturers as well as other end markets.

And with the company, I'm happy to have Jon Lyons, CFO; and Jason Peterson, Investor Relations. Jon, thanks for joining us.

Jonathan Lyons
Senior VP & CFO

Thanks a lot, Ryan. Good to be here.

Question-and-Answer Session

Ryan Halsted
RBC Capital Markets, Research Division

I wanted to start with the leadership transition that you guys announced recently. Just wanted to get an update, any more details on the succession time line and any perspectives you could add just on Alton's background and experience that you're excited to have on board.

Jonathan Lyons
Senior VP & CFO

Great. Thanks. And before we get started, I do have to cover the legal side. So I may make some forward-looking statements today. Please refer to our SEC filings for a list of risks and uncertainties related to those. And now, I'll answer your question.

So no, we're excited. I'm excited. I had a chance to talk to Alton a couple of times since he's been appointed. The Board ran an exhaustive search in coordination with Michael, really looking for the right person for the role.

Just from a timing perspective, I think Michael was interested in taking a little bit of a turn. His view is that the role should be -- CEO